Chase Investment Counsel’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,009
| Closed | -$330K | – | 154 |
|
|
2024
Q4 | $330K | Hold |
1,009
| – | – | 0.11% | 118 |
|
|
2024
Q3 | $302K | Hold |
1,009
| – | – | 0.1% | 115 |
|
|
2024
Q2 | $332K | Sell |
1,009
-31
| -3% | -$10.2K | 0.12% | 112 |
|
|
2024
Q1 | $411K | Hold |
1,040
| – | – | 0.15% | 104 |
|
|
2023
Q4 | $366K | Buy |
+1,040
| New | +$366K | 0.16% | 107 |
|
|
2017
Q1 | – | Sell |
-5,980
| Closed | -$507K | – | 104 |
|
|
2016
Q4 | $507K | Sell |
5,980
-2,355
| -28% | -$200K | 0.25% | 73 |
|
|
2016
Q3 | $620K | Sell |
8,335
-500
| -6% | -$37.2K | 0.27% | 70 |
|
|
2016
Q2 | $670K | Sell |
8,835
-485
| -5% | -$36.8K | 0.3% | 70 |
|
|
2016
Q1 | $646K | Buy |
+9,320
| New | +$646K | 0.28% | 66 |
|
|
2014
Q1 | – | Sell |
-35,270
| Closed | -$1.73M | – | 117 |
|
|
2013
Q4 | $1.73M | Sell |
35,270
-19,290
| -35% | -$946K | 0.51% | 64 |
|
|
2013
Q3 | $2.25M | Buy |
54,560
+60
| +0.1% | +$2.47K | 0.58% | 40 |
|
|
2013
Q2 | $1.91M | Buy |
+54,500
| New | +$1.91M | 0.51% | 45 |
|